Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size, Share, Trends and Forecast 2022-2030

Description

A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
Industry Insights

Due to the COVID-19 pandemic, the global T-Cell & NK-Cell Engaging Bispecific Antibodies market size is estimated to be worth US$ 472 million in 2021 and is forecast to a readjusted size of US$ 5107.7 million by 2028 with a CAGR of 41.0% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe T-Cell & NK-Cell Engaging Bispecific Antibodies market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe T-Cell & NK-Cell Engaging Bispecific Antibodies landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.

This report focuses on T-Cell & NK-Cell Engaging Bispecific Antibodies volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall T-Cell & NK-Cell Engaging Bispecific Antibodies market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and Europe., etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the T-Cell & NK-Cell Engaging Bispecific Antibodies market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

T-Cell Engagers

NK-Cell Engagers

Segment by Application

Hematological Cancers

Solid Tumors

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Amgen

Immunocore

Johnson & Johnson

Roche

Pfizer

AbbVie

MacroGenics

Regeneron

TABLE OF CONTENT

1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview
1.1 Product Overview and Scope of T-Cell & NK-Cell Engaging Bispecific Antibodies

1.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Type

1.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 T-Cell Engagers

1.2.3 NK-Cell Engagers

1.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Segment by Application

1.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Comparison by Application: (2022-2028)

1.3.2 Hematological Cancers

1.3.3 Solid Tumors

1.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Estimates and Forecasts

1.4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue 2017-2028

1.4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales 2017-2028

1.4.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region: 2017 Versus 2021 Versus 2028

2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competition by Manufacturers

2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Manufacturers (2017-2022)

2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Manufacturers (2017-2022)

2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Manufacturers (2017-2022)

2.4 Manufacturers T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Sites, Area Served, Product Type

2.5 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competitive Situation and Trends

2.5.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest T-Cell & NK-Cell Engaging Bispecific Antibodies Players Market Share by Revenue

2.5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 T-Cell & NK-Cell Engaging Bispecific Antibodies Retrospective Market Scenario by Region

3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country

3.3.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country

3.3.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country

3.4.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country

3.4.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Region

3.5.1 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region

3.5.2 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country

3.6.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country

3.6.2 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country

3.7.1 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country

3.7.2 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Analysis by Type

4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2017-2022)

4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2017-2022)

4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2017-2022)

5 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Historic Market Analysis by Application

5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2017-2022)

5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2017-2022)

5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Amgen

6.1.1 Amgen Corporation Information

6.1.2 Amgen Description and Business Overview

6.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

6.1.5 Amgen Recent Developments/Updates

6.2 Immunocore

6.2.1 Immunocore Corporation Information

6.2.2 Immunocore Description and Business Overview

6.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

6.2.5 Immunocore Recent Developments/Updates

6.3 Johnson & Johnson

6.3.1 Johnson & Johnson Corporation Information

6.3.2 Johnson & Johnson Description and Business Overview

6.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

6.3.5 Johnson & Johnson Recent Developments/Updates

6.4 Roche

6.4.1 Roche Corporation Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Corporation Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 AbbVie

6.6.1 AbbVie Corporation Information

6.6.2 AbbVie Description and Business Overview

6.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)

6.6.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

6.6.5 AbbVie Recent Developments/Updates

6.7 MacroGenics

6.6.1 MacroGenics Corporation Information

6.6.2 MacroGenics Description and Business Overview

6.6.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)

6.4.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

6.7.5 MacroGenics Recent Developments/Updates

6.8 Regeneron

6.8.1 Regeneron Corporation Information

6.8.2 Regeneron Description and Business Overview

6.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio

6.8.5 Regeneron Recent Developments/Updates

7 T-Cell & NK-Cell Engaging Bispecific Antibodies Manufacturing Cost Analysis

7.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies

7.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors List

8.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Customers

9 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Dynamics

9.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Trends

9.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers

9.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges

9.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints

10 Global Market Forecast

10.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of T-Cell & NK-Cell Engaging Bispecific Antibodies by Type (2023-2028)

10.1.2 Global Forecasted Revenue of T-Cell & NK-Cell Engaging Bispecific Antibodies by Type (2023-2028)

10.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of T-Cell & NK-Cell Engaging Bispecific Antibodies by Application (2023-2028)

10.2.2 Global Forecasted Revenue of T-Cell & NK-Cell Engaging Bispecific Antibodies by Application (2023-2028)

10.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of T-Cell & NK-Cell Engaging Bispecific Antibodies by Region (2023-2028)

10.3.2 Global Forecasted Revenue of T-Cell & NK-Cell Engaging Bispecific Antibodies by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample